Skip to content
Disclosery

J. Goldman & Co LP: GMED position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of J. Goldman & Co LP on GMED, newest first. How the timeline and the estimate are built.

J. Goldman & Co LP held 0 GMED shares at 2026-03-31 per its 13F-HR filed 2026-05-15.

the latest 13F is the newest step

  1. period ended2026-03-31
    13F 0 shares
    Change vs previous 13F -204,827 shares

    13F-HR 0001412741-26-000002 filed by J. Goldman & Co LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-12-31
    13F 204,827 shares
    Change vs previous 13F -814,490 shares

    0.7% of the 13F portfolio, value $17,883,445.

    13F-HR 0001412741-26-000001 filed by J. Goldman & Co LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-09-30
    13F 1,019,317 shares
    Change vs previous 13F +387,569 shares

    2.21% of the 13F portfolio, value $58,376,285.

    13F-HR 0001412741-25-000008 filed by J. Goldman & Co LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-06-30
    13F 631,748 shares
    Change vs previous 13F not available

    1.17% of the 13F portfolio, value $37,285,767.

    13F-HR 0001085146-25-005095 filed by J. Goldman & Co LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).